The Arabidopsis cell wall-associated kinase (WAK) and WAK-like kinase (WAKL) family of receptor-like kinase genes encodes transmembrane proteins with a cytoplasmic serine/threonine kinase domain and an extracellular region containing epidermal growth factor-like repeats. Previous studies have suggested that some WAK members are involved in plant defense and heavy metal responses, whereas others are required for cell elongation and plant development. The WAK/WAKL gene family consists of 26 members in Arabidopsis and can be divided into four groups. Here, we describe the characterization of group 2 members that are composed of a cluster of seven tandemly arrayed WAKL genes. The predicted WAKL proteins are highly similar in their cytoplasmic region but are more divergent in their predicted extracellular ligand-binding region. WAKL7 encodes a truncated WAKL isoform that is predicted to be secreted from the cytoplasm. Ratios of nonsynonymous to synonymous substitutions suggest that the extracellular region is subject to diversifying selection. Comparison of the WAKL and WAK gene clusters suggests that they arose independently. Protein gel-blot and immunolocalization analyses suggest that WAKL6 is associated with the cell wall. Histochemical analyses of WAKL promoters fused with the beta-glucuronidase reporter gene have shown that the expressions of WAKL members are developmentally regulated and tissue specific. Unlike WAK members whose expressions were found predominately in green tissues, WAKL genes are highly expressed in roots and flowers. The expression of WAKL5 and WAKL7 can be induced by wounding stress and by the salicylic acid analog 2,6-dichloroisonicotinic acid in an nonexpressor of pathogenesis-related gene 1-dependent manner, suggesting that they, like some WAK members, are wound inducible and can be defined as pathogenesis-related genes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC300728PMC
http://dx.doi.org/10.1104/pp.103.028530DOI Listing

Publication Analysis

Top Keywords

wak members
12
developmentally regulated
8
cluster tandemly
8
tandemly arrayed
8
cell wall-associated
8
kinase genes
8
wakl
8
extracellular region
8
wakl genes
8
members
6

Similar Publications

Article Synopsis
  • Protein kinases are crucial for plant growth and responses to stress, but research on these proteins in sunflowers is limited compared to other crops like soybean and cotton.
  • A comprehensive study identified 2,583 protein kinases in sunflowers, classifying them into 22 families and 121 subfamilies, with three specific subfamilies showing significant growth.
  • The research also analyzed how these kinases respond to different stresses, ultimately identifying 73 key protein kinases involved in essential signaling pathways, contributing valuable foundational data to the field.
View Article and Find Full Text PDF

Describing and characterizing the gene family across plant species: a systematic review.

Front Plant Sci

November 2024

Hans Merensky Chair in Avocado Research, Forestry & Agricultural Biotechnology Institute (FABI), Department of Biochemistry, Genetics and Microbiology (BGM), University of Pretoria, Pretoria, South Africa.

Wall-associated kinases (WAKs) and WAK-likes (WAKLs) are transmembrane pectin receptors which have seen rising interest in recent years due to their roles in stress responses and developmental pathways. Consequently, the genes encoding these proteins are continuously identified, described and characterised across a wide variety of plant species. The primary goal of characterizing these genes is to classify, describe and infer cellular function, mostly through methods.

View Article and Find Full Text PDF

CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis.

AJNR Am J Neuroradiol

September 2024

From the Inst. of Neuroradiology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany (T.A.); Dept. of Neuroradiology, University Hospital Augsburg, Germany (B.B.); Neuroradiological Reference Center for the pediatric brain tumor (HIT) studies of the German Society of Pediatric Oncology and Hematology, Faculty of Medicine, University Augsburg, Augsburg, Germany (B.B.); Service de Neurochirurgie B, CHU de Bordeaux, University of Bourdeaux, France (E.J.); Univ. Bordeaux, Bordeaux INP, CNRS, IMB, UMR 5251, Talence, France (E.J.); Institut de Pathologie Multisite-Site Est, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France (F.T., M.D., V.A.); Aix- Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France (FB.D.); Dept. of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (G.E.); Dept. of Clinical Radiology, Kuopio University Hospital, Kuopio, Finland (H.J.); Inst. of Clinical Medicine, University of Eastern Finland, Kuopio, Finland (H.J.); Dept. of Pediatric Oncology/Hematology/Immunology, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany (K.E.); Murdoch Children's Research Inst., The Royal Children's Hospital, Flemington Road, Parkville, Victoria, Australia (L.LE); Children's Cancer Centre, The Royal Children's Hospital, Flemington Road, Parkville, Victoria, 3052, Australia (L.LE); Dept. of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia (L.LE); Crown Princess Victoria Children's Hospital, Linköping University Hospital, Linköping, Sweden (N.P.); Dept. of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden (N.P.); Dept. of Pediatric Oncology and Hematology, Skåne University Hospital, Lund University, Lund, Sweden (Ø.I); Dept. of Pediatrics, Pediatric Hematology and Oncology Ward, Kuopio University Hospital and Inst. of Clinical Medicine, University of Eastern Finland, Kuopio, Finland (P.J.); Dept. of Clinical Pathology, Kuopio University Hospital and Unit of Pathology, Inst. of Clinical Medicine, University of Eastern Finland, Kuopio, Finland (R.T.); Dept. of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands (R.RE.); Dept. of Hematology-Oncology, Valley Children's Hospital, Madera, CA, USA (S.D.); Rare Cancers Genomics Team, Genomic Epidemiology Branch, International Agency for Research on Cancer/World Health Organization, Lyon, France (S-O.A.); Inst. of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (W.A.K.); Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (W.A.K.); Dept. of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic (Z.J.); Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany (J.D.T.W., K.M.K.); Division of Pediatric Glioma Research (B360), German Cancer Research Center (DKFZ), Heidelberg, Germany (J.D.T.W., K.M.K.); National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Germany (J.D.T.W., K.M.K.); Dept. of Pediatric Oncology and Hematology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Inst. of Health, Berlin, Germany (V.H.K.); Dept. of Paediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark (V.H.K.); (European Society for Paediatric Oncology (SIOPE)-Brain Tumour Group.

Background And Purpose: CNS embryonal tumor with amplification (ET, PLAGL) is a newly identified, highly malignant pediatric tumor. Systematic MRI descriptions of ET, PLAGL are currently lacking.

Materials And Methods: MRI data from 19 treatment-naïve patients with confirmed ET, PLAGL were analyzed.

View Article and Find Full Text PDF

Generating Synthetic Data for Medical Imaging.

Radiology

September 2024

From the Delft University of Technology, Delft, the Netherlands (L.R.K.); Segmed, 3790 El Camino Real #810, Palo Alto, CA 94306 (J.W., A.L., M.C., W.A.K., J.P., M.J.W.); Department of Radiology, University of Washington, Seattle, Wash (D.M.); Department of Radiology, OncoRad/Tumor Imaging Metrics Core, Seattle, Wash (D.M.); Harvard University, Cambridge, Mass (J.P.); Department of Radiology, Stanford University School of Medicine, Palo Alto, Calif (A.S.C.); Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, Calif (A.S.C.); Department of Biomedical Informatics, Harvard Medical School, Boston, Mass (P.R.); Microsoft, Redmond, Wash (M.P.L.); and Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, Calif (M.P.L.).

Article Synopsis
  • AI models for medical imaging need large and diverse datasets, which are hard to obtain due to privacy concerns and data sharing issues.
  • Synthetic medical imaging data, generated by AI, can help address these shortages while allowing for new applications and professional training.
  • However, using synthetic data raises challenges related to realism, evaluation of model performance, high costs, and the need for updated regulations to ensure ethical use, highlighting the importance of collaboration between regulatory bodies, physicians, and AI developers.
View Article and Find Full Text PDF

Background: Nutrition plays a vital role in the outcome of critically ill children, particularly those with AKI. Currently, there are no established guidelines for children with AKI treated with continuous RRT (CRRT). A thorough understanding of the metabolic changes and nutritional challenges in AKI and CRRT is required.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!